The Lancet Neurology has published the results of a trial involving stem cell transplantation in people with relapsing remitting multiple sclerosis (MS).
The results of the Chicago study of around 20 people show that the treatment halted progression of disability and could potentially reverse the damage caused in MS.
. Have a Question, Comment or information for others? If so, please use the post comment link found below. Your name and email address would be appreciated but is not necessary unless you want a response from others. Thank You ============================================
Stem Cell transplant trial results - The Lancet Neurology
The Lancet Neurology has published the results of a trial involving stem cell transplantation in people with relapsing remitting multiple sclerosis (MS).
The results of the Chicago study of around 20 people show that the treatment halted progression of disability and could potentially reverse the damage caused in MS.
» Read more.
Have a Question, Comment or information for others? If so, please use the post comment link found below. Your name and email address would be appreciated but is not necessary unless you want a response from others. Thank You
============================================